Ferrari teams gear up for multiple European racing events this weekend

Benedetto Vigna Chief Executive Officer Ferrari N.V.
Benedetto Vigna Chief Executive Officer - Ferrari N.V.
0Comments

Ferrari teams are set to compete in various racing events across Europe this weekend. The schedule includes the DTM at Norisring, Germany; the European Le Mans Series at Imola, Italy; the International GT Open in Budapest, Hungary; the 24H Series at Paul Ricard, France; and the Britcar Endurance Championship at Thruxton, England.

In the DTM event at Norisring, Emil Frey Racing will field two Ferrari 296 GT3s. Jack Aitken is currently seventh in the standings with 68 points, while Thierry Vermeulen holds 16th place with 20 points. The race weekend begins on Friday with free practice, followed by qualifying on Saturday morning and Race-1 from 1:30 to 2:30 p.m. Race-2 will take place on Sunday afternoon.

The European Le Mans Series returns to Imola for its third round. Seven Ferrari 296 LMGT3s will participate. The number 50 Richard Mille AF Corse entry is second in the standings and aims to close a four-point gap to the top. Qualifying takes place on Saturday from 2:30 p.m., with a four-hour race starting Sunday at noon.

The International GT Open’s fourth round occurs at Budapest’s Hungaroring circuit. Seven Ferraris will compete across different classes. In the Pro category, Elite Motorsport and AF Corse entries are notable participants. Free practice starts on Friday, with races scheduled for Saturday and Sunday.

In France, three Ferrari 296 GT3s will compete in round four of the Michelin 24H Series Europe at Paul Ricard. Scuderia Praha leads both overall and Pro-Am class standings but faces strong competition from Era Motorsport and Dragon Racing Xollie teams.

Finally, Bonamy Grimes and Johnny Mowlem will drive a Ferrari 488 Challenge Evo in England’s Britcar Endurance Championship at Thruxton. The event features free practice and qualifying sessions in the morning followed by two races in the afternoon.

All times mentioned are local to each venue.



Related

Paul Hudson Chief Executive Officer Sanofi SA

Acoziborole receives key EU panel backing as single-dose treatment for sleeping sickness

Acoziborole Winthrop, a new oral treatment for sleeping sickness developed by the Drugs for Neglected Diseases initiative (DNDi) and Sanofi, has received a positive opinion from the European Medicines Agency’s Committee for Medicinal Products for…

Martin Lundstedt President and CEO at Volvo Group North America LLC Volvo Group North America LLC

Volvo announces updated share and vote count after series conversion

The number of votes in AB Volvo has changed following the conversion of 2,000,619 Series A shares into an equal number of Series B shares.

Paul Hudson Chief Executive Officer Sanofi SA

Sanofi and Regeneron’s Dupixent recommended for EU approval in young children with chronic urticaria

Sanofi and Regeneron have announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending approval of Dupixent (dupilumab) for children aged two to 11 years with…

Trending

The Weekly Newsletter

Sign-up for the Weekly Newsletter from EU Business Daily.